Notification
No new Notification messages
Niva Bupa Health Insurance IPO is Open!
Apply for the Niva Bupa Health Insurance IPO through UPI in just minutes.
Q2 FY'24-25 Results of Top Companies
Reliance, TCS, HDFC Bank & more: Explore key financial highlights from India's top quarterly results.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Diwali Offer: MTF at just 9.99%
Iss Diwali, Investments Ko Karo 4X with our Trade Now, Pay Later (MTF) feature
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Biocon Biologics Refinances ₹9,100 crore Debt with Bonds and Syndicated Facility

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Synopsis:

Biocon Biologics refinances ₹9,100 crore debt through ₹6,600 crore bonds and a syndicated debt facility. The refinancing is set to improve liquidity and drive reinvestment into its biosimilars pipeline.

Biocon Biologics Limited (BBL), a subsidiary of Biocon, has successfully priced its ₹6,600 crore senior secured notes, due in 2029, with a 6.67% coupon. The bond issuance, backed by robust collateral, is part of a broader strategy to refinance existing ₹9,100 crore debt, enhancing the company’s liquidity.

BIOCON LIMITED.

Trade

341.420.10 (6.25 %)

Updated - 11 November 2024
343.35day high
DAY HIGH
326.00day low
DAY LOW
11403875
VOLUME (BSE)

In addition to the bond, BBL has secured a new syndicated debt facility through a commitment agreement. The proceeds will be used to strengthen its capital structure, allowing Biocon Biologics to reinvest in its biosimilars pipeline and drive long-term growth. CEO Shreehas Tambe stated that this refinancing would also diversify the company’s investor base by attracting global healthcare investors.

As of 12:45 PM on October 3, 2024, Biocon Ltd’s share price is trading at ₹359.50, reflecting a 3.01% decline. The share price has been closely watched as this refinancing is expected to boost confidence in the company’s financial flexibility. This bond issuance is scheduled to settle on October 9, subject to customary conditions.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5000+ Cr MTF Book

icon-with-text